Shanghai Henlius Biotech, launched by former Amgen executive Scott Liu Shi-kau, is working on 16 cancer drugs that are undergoing clinical trials or awaiting approval for marketing.
Shanghai Henlius Biotech, launched by former Amgen executive Scott Liu Shi-kau, is working on 16 cancer drugs that are undergoing clinical trials or awaiting approval for marketing.
Budweiser Brewing Company APAC said on Tuesday that it plans to raise up to US$4.8 billion and add Singapore sovereign wealth fund GIC Private Limited as a cornerstone investor as it revives its slimmed-down Hong Kong IPO.
ESR Cayman warns there is ‘no assurance’ the offering will proceed; it had previously hoped to raise up to US$698.8 million in net proceeds.
ESR Cayman warns there is ‘no assurance’ the offering will proceed; it had previously hoped to raise up to US$698.8 million in net proceeds.
Budweiser Brewing Company APAC says there is no guarantee that the IPO will go ahead despite resuming its IPO application.
Budweiser Brewing Company APAC says there is no guarantee that the IPO will go ahead despite resuming its IPO application.
